Tg(Vpreb1-IL2RB)F133Ilm
Transgene Detail
|
Symbol: |
Tg(Vpreb1-IL2RB)F133Ilm |
Name: |
transgene insertion F133, Inga-Lill Martensson |
MGI ID: |
MGI:5505492 |
Synonyms: |
-214BpreB1-huCD122 line F133, Tg(-214VpreB1-huCD122)F133Lmb, Tg(214VpreB1-huCD122)F133mb |
Transgene: |
Tg(Vpreb1-IL2RB)F133Ilm Location: unknown
|
Alliance: |
Tg(Vpreb1-IL2RB)F133Ilm page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Vpreb1-IL2RB)F133Ilm expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
IL2RB (3560) |
|
|
|
|
|
Mutation details: This transgenic insertion comprises 10 copies, as determined by dot blot and Southern blot analysis, of a 3.7-kb construct containing the mouse pre-B lymphocyte gene 1 (Vprb1) promoter and enhancer (nt -214 to +142, counting the 5'-most transcriptional initiation site as +1) driving expression of the human interleukin 2 receptor, beta (IL2RB, also called CD122) cDNA, which is followed by exon 2, intron 2, exon 3 and the polyadenylation signal of the human beta-globin gene. Semi-quantitative reverse transcription- (RT-) PCR analysis reveals transgene expression at high levels in bone marrow (BM) and thymus and low to very low levels in spleen, brain and muscle; signal is undetectable in liver. Similar analysis of sorted BM cells from mice of this line reveals expression in the B220+Igm- pro-/pre-B cell, but not in the B220+Igm+ immature/mature B cell population, concordant with the expression pattern of native Vpreb1. Flow cytometric analysis demonstrates that the human IL2RB marker is present on ~10% of B220low/int (characteristic of pro-/pre- and immature B) cells, but not on B220high (mature B) cells nor on B220- cells.
(J:199513)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 2 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:199513 Licence S, et al., The VpreB1 enhancer drives developmental stage-specific gene expression in vivo. Eur J Immunol. 2003 Apr;33(4):1117-26 |
All: |
1 reference(s) |
|